Hint mode is switched on Switch off

Nkarta, ordinary share
NKTX, US65487U1088

Add a stock to WL
Choose all Reset all
Nkarta, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Nkarta Inc operates as a biotech company. The Company develops and discovers therapies for immune systems and cancer indications. Nkarta serves patients in the State of California.
  • Issuer
  • Full borrower / issuer name
    Nkarta Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    NKTX
  • Placement
    10.07.2020
  • Lock up period
    180
  • Number of papers
    14,000,000
  • Volume of raised funds
    252 mln USD
  • Placement share
    46.01%
  • Final placement price
    18 USD
  • Price change since placement date
    -86.53%
  • By capitalization
    547.7 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    NKTX
  • Placement
    26.04.2022
  • Lock up period
    180
  • Number of papers
    13,333,334
  • Volume of raised funds
    200 mln USD
  • Placement share
    28.79%
  • Final placement price
    15 USD
  • Price change since placement date
    -83.83%
  • By capitalization
    694.57 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    NKTX
  • Placement
    26.03.2024
  • Lock up period
    180
  • Number of papers
    70,191,295
  • Volume of raised funds
    210.1 mln USD
  • Placement share
    29.93%
  • Final placement price
    10 USD
  • Price change since placement date
    -75.75%
  • By capitalization
    701.91 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

25/03/2026 Nkarta: Other Events, Financial Statements And Exhibits
03/06/2025 Nkarta: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders, Regulation Fd Disclosure, Financial Statements And Exhibits
14/05/2025 Nkarta: Results Of Operations And Financial Condition, Financial Statements And Exhibits
26/03/2025 Nkarta: Results Of Operations And Financial Condition, Costs Associated With Exit Or Disposal Activities, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Other Events, Financial Statements And Exhibits
07/11/2024 Nkarta: Results Of Operations And Financial Condition, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.